共 3 条
- [1] Brolucizumab—early real-world experience: BREW studyEye, 2021, 35 : 1045 - 1047Ashish Sharma论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Nilesh Kumar论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Nikulaa Parachuri论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Srinivas R. Sadda论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Giulia Corradetti论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Jeffrey Heier论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Adam T. Chin论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,David Boyer论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Pouya Dayani论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Sruthi Arepalli论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Peter Kaiser论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,
- [2] Correction: Brolucizumab—early real-world experience: BREW studyEye, 2021, 35 (4) : 1286 - 1286Ashish Sharma论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Doheny Eye Institute Los Angeles CA USA, Department of Ophthalmology David Geffen School of MedicineNilesh Kumar论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Doheny Eye Institute Los Angeles CA USA, Department of Ophthalmology David Geffen School of MedicineNikulaa Parachuri论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Doheny Eye Institute Los Angeles CA USA, Department of Ophthalmology David Geffen School of MedicineSrinivas R. Sadda论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Doheny Eye Institute Los Angeles CA USA, Department of Ophthalmology David Geffen School of MedicineGiulia Corradetti论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Doheny Eye Institute Los Angeles CA USA, Department of Ophthalmology David Geffen School of MedicineJeffrey Heier论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Doheny Eye Institute Los Angeles CA USA, Department of Ophthalmology David Geffen School of MedicineAdam T. Chin论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Doheny Eye Institute Los Angeles CA USA, Department of Ophthalmology David Geffen School of MedicineDavid Boyer论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Doheny Eye Institute Los Angeles CA USA, Department of Ophthalmology David Geffen School of MedicinePouya Dayani论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Doheny Eye Institute Los Angeles CA USA, Department of Ophthalmology David Geffen School of MedicineSruthi Arepalli论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Doheny Eye Institute Los Angeles CA USA, Department of Ophthalmology David Geffen School of MedicinePeter Kaiser论文数: 0 引用数: 0 h-index: 0机构: Lotus Eye Hospital and Institute,Doheny Eye Institute Los Angeles CA USA, Department of Ophthalmology David Geffen School of Medicine
- [3] REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal (September, 10.1007/s10072-020-04726-6, 2020)NEUROLOGICAL SCIENCES, 2021, 42 (02) : 767 - 767Batista, S.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp & Univ Coimbra, Praceta Prof Mota Pinto, P-3000075 Coimbra, Portugal Ctr Hosp & Univ Coimbra, Praceta Prof Mota Pinto, P-3000075 Coimbra, PortugalNunes, C. C.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp & Univ Coimbra, Praceta Prof Mota Pinto, P-3000075 Coimbra, Portugal Ctr Hosp & Univ Coimbra, Praceta Prof Mota Pinto, P-3000075 Coimbra, Portugal论文数: 引用数: h-index:机构:Silva, Ana Martins论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ Porto, Porto, Portugal Univ Porto, Inst Ciencias Biomed Abel Salazar, Unidade Multidisciplinar Invest Biomed, Porto, Portugal Ctr Hosp & Univ Coimbra, Praceta Prof Mota Pinto, P-3000075 Coimbra, Portugalde Sa, J. Correia论文数: 0 引用数: 0 h-index: 0机构: Hosp Santa Maria, Ctr Hosp Lisboa Norte EPE, Lisbon, Portugal Ctr Hosp & Univ Coimbra, Praceta Prof Mota Pinto, P-3000075 Coimbra, PortugalFerreira, J.论文数: 0 引用数: 0 h-index: 0机构: Hosp Santa Maria, Ctr Hosp Lisboa Norte EPE, Lisbon, Portugal Ctr Hosp & Univ Coimbra, Praceta Prof Mota Pinto, P-3000075 Coimbra, PortugalMendonca, M. T.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Sao Joao, Porto, Portugal Ctr Hosp & Univ Coimbra, Praceta Prof Mota Pinto, P-3000075 Coimbra, PortugalPinheiro, J.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Vila Nova Gaia, Vila Nova De Gaia, Portugal Ctr Hosp & Univ Coimbra, Praceta Prof Mota Pinto, P-3000075 Coimbra, PortugalSalgado, V.论文数: 0 引用数: 0 h-index: 0机构: Hosp Prof Doutor Fernando Fonseca EPE, Amadora, Portugal Ctr Hosp & Univ Coimbra, Praceta Prof Mota Pinto, P-3000075 Coimbra, PortugalCorreia, A. S.论文数: 0 引用数: 0 h-index: 0机构: Hosp Egas Moniz, Ctr Hosp Lisboa Ocidental EPE, Lisbon, Portugal Ctr Hosp & Univ Coimbra, Praceta Prof Mota Pinto, P-3000075 Coimbra, PortugalSequeira, J.论文数: 0 引用数: 0 h-index: 0机构: Hosp Santo Antonio Capuchos, Ctr Hosp Univ Lisboa Cent EPE, Lisbon, Portugal Ctr Hosp & Univ Coimbra, Praceta Prof Mota Pinto, P-3000075 Coimbra, PortugalCosta, A.论文数: 0 引用数: 0 h-index: 0机构: Novartis Farma, Lisbon, Portugal Ctr Hosp & Univ Coimbra, Praceta Prof Mota Pinto, P-3000075 Coimbra, PortugalSousa, L.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp & Univ Coimbra, Praceta Prof Mota Pinto, P-3000075 Coimbra, Portugal Ctr Hosp & Univ Coimbra, Praceta Prof Mota Pinto, P-3000075 Coimbra, Portugal